Boston, MA 03\/28\/2014 (wallstreetpr) –\u00a0Curis, Inc. (NASDAQ:CRIS) <\/b>which is involved in drug technologies is keeping up with a good fight. However, analysts are still bearish on the stock, but this can only serve as indications that a lot of upside is still available in the stock. Analysts at Roth Capital had little to celebrate in the stock in the recent note to investors discussing CRIS. The analysts trimmed their price target in the stock to $9 from $10. Shares suffered on that note. In the latest reporting, Curis, Inc. (NASDAQ:CRIS) fared nicely with EPS that beat expectation at 5 cents loss against 8 cents loss that Wall Street modeled. However, revenue was a different story, coming in at $1.52 million, below the expected $1.59 million.<\/p>\n
\u00a0The analyst tone in BRF SA (ADR) (NYSE:BRFS)<\/b> has changed a great deal in the past few weeks, and all that is for the wrong reason. The short of it is that investors eying this stock should tread carefully in that analysts believe that it could be headed for a slump. The stock is up more than 16 percent in the last four weeks, yes, but over the same period, analysts have increasingly placed it on the chopping board, recommending sell. Among the scares in BRF SA (ADR) (NYSE:BRFS) is its 74.7 RSI value, and then think that Zacks has it as a perfect sell.<\/p>\n
With the hype and sometimes confusion that characterize medical marijuana industry, United Treatment Centers Inc (OTCMKTS:UTRM)<\/b> wants to carve a niche and push forward to profitability. Owing to its already significant knowledge and information base in matters medicine, the company seeks to be the reliable and perhaps one-stop shop for all news and information about medical cannabis and related businesses, thanks to the legalization of medical pot. While many other companies are racing up and down to invest in the emerging industry directly by either providing equipment for growers or processing hemp, UTRM believes that such investors will need credible information and this something which is already lacking. And this has opened a business opportunity for United Treatment Centers Inc (OTCMKTS:UTRM).<\/p>\n","protected":false},"excerpt":{"rendered":"
Boston, MA 03\/28\/2014 (wallstreetpr) –\u00a0Curis, Inc. (NASDAQ:CRIS) which is involved in drug technologies is keeping up with a good fight. However, analysts are still bearish […]<\/p>\n","protected":false},"author":12,"featured_media":18288,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[1942,4085],"tags":[5675,5673,5674,1132,5677,5676],"stock_ticker":[],"class_list":["post-18285","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-banking","category-analyst-reports-on-stocks","tag-brf-sa-adr-nysebrfs","tag-curis-inc-nasdaqcris","tag-nasdaqcris","tag-nysebrfs","tag-otcmktsutrm","tag-united-treatment-centers-inc-otcmktsutrm","entry"],"acf":[],"yoast_head":"\n